Calcium Channel Blocker Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Calcium Channel Blocker Market Through 2025?
The market size for calcium channel blockers has seen a significant surge in growth in the past few years. The market is projected to increase from $15.56 billion in 2024 and reach $16.46 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historical period include a rise in cases of cardiovascular diseases, an aging population, advancements in medical research, lifestyle changes, and heightened awareness.

What's the Projected Size of the Global Calcium Channel Blocker Market by 2029?
The market for calcium channel blockers is forecasted to experience considerable expansion in the upcoming years, with a projection to reach "$21.59 billion by 2029" following a compound annual growth rate (CAGR) of 7.0%. The anticipated increase during the forecast period can be linked to the escalating worldwide incidence of cardiovascular diseases, trends in personalized medicine, improved healthcare accessibility, broadening of indications, regulatory green lights, and market growth. Key trends throughout the forecast period encompass market expansion, advancements in technology, regulatory changes, competitive scrutiny, patient choices, and awareness.

View the full report here:
https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report

Top Growth Drivers in the Calcium Channel Blocker Industry: What's Accelerating the Market?
The rise in cases of cardiovascular diseases is projected to propel the growth of the calcium channel blocker market. Cardiovascular diseases are conditions that impact the heart or blood vessels, and calcium channel blockers (CCBs) are commonly used to decrease the risk of heart failure and stroke. Thus, with an increase in these diseases, there will be a corresponding spike in demand for calcium channel blockers. For example, in August 2022, the American College of Cardiology, a non-profit medical association based in the U.S., reported that all four cardiac risk factors are projected to surge between 2025 and 2060 in the U.S. Diabetes is predicted to see the greatest percentage increase, with a 39.3% rise to 55 million people, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also noted significant anticipated rises in rates of cardiovascular diseases, most notably in stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). As such, the growing incidence rate of cardiovascular diseases is fueling the advancement of the calcium channel blocker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9428&type=smp

What Are the Key Trends Driving Calcium Channel Blocker Market Growth?
The primary trend that is gaining traction in the calcium channel blocker market is product innovation. This is highlighted by the efforts of large corporations in the sector to create unique products in efforts to maintain their market standing. For instance, in June 2022, CMP Pharma, a U.S. pharmaceutical manufacturer, introduced Norliqva, the first-ever oral liquid solution of the besylate salt of amlodipine, a long-acting calcium channel blocker. What sets Norliqva apart is that it is an amlodipine liquid solution designed to manage hypertension in individuals over the age of 6. It eliminates the challenges of crushing or synthesizing amlodipine tablets and assures consistent dosing and bioequivalence. It is specially designed for a group of patients who need amlodipine but struggle with or are incapable of swallowing.

What Are the Main Segments in the Calcium Channel Blocker Market?
The calcium channel blocker market covered in this report is segmented -

1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes
2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine
2) By Benzodiazepine: Diazepam
3) By Phenylalkylamine: Verapamil
4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9428&type=smp

Which Top Companies are Driving Growth in the Calcium Channel Blocker Market?
Major companies operating in the calcium channel blocker market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd.

Which Regions Will Dominate the Calcium Channel Blocker Market Through 2029?
North America was the largest region in the calcium channel blocker market in 2024. The regions covered in the calcium channel blocker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9428

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.